# Lupin Receives U.S. FDA Approval for Amifampridine Tablets

- Source: PR Newswire M&A
- Published: 2026-11-02T14:45:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/lupin-receives-us-fda-approval-for-amifampridine-tablets-302926546.html
- Canonical: https://groundlevelnews.com/story/lupin-receives-u-s-fda-approval-for-amifampridine-tablets-e61105/

As the First-To-File, Lupin is Eligible for 180-Day Shared Generic Exclusivity MUMBAI, India and NAPLES, Fla., Nov. 2, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._